{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-046023","form_type":"8-K","ticker":"XENE","cik":"0001582313","company_name":"Xenon Pharmaceuticals Inc.","filed_at":"2024-04-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.069853+00:00","generated_at":"2026-06-03T16:00:12.347639+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Xenon Pharmaceuticals chair Simon Pimstone and director Mohammad Azab not standing for re-election","bullets":["Chair Simon Pimstone and board member Mohammad Azab will not stand for re-election at 2024 annual meeting.","Both directors will continue to serve until the AGM; departures are not due to any disagreement with company.","No replacements announced yet; board size and composition will change after AGM."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-046023","json":"https://secwatch.observer/filing/0000950170-24-046023.json","markdown":"https://secwatch.observer/filing/0000950170-24-046023.md","text":"https://secwatch.observer/filing/0000950170-24-046023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1582313/000095017024046023/0000950170-24-046023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1582313/000095017024046023/xene-20240415.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T16:00:12.347639+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2f10c9a4b9","claim":"Mohammad Azab departed as Member of the Board at Xenon Pharmaceuticals Inc..","evidence_excerpt":"On April 15, 2024, Dr. Simon Pimstone, chair of the board of directors (the “Board”) of Xenon Pharmaceuticals Inc. (the “Company”), and Dr. Mohammad Azab, a member of the Board, each informed the Company of their respective decisions not to stand for re-election to the Board at the Company’s 2024 annual meeting of shareholders (the “AGM”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017024046023/0000950170-24-046023-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"Member of the Board"}],"fact_type":"executive_change"},{"claim_id":"d4ad3ed6d6","claim":"Simon Pimstone departed as Chair of the Board at Xenon Pharmaceuticals Inc..","evidence_excerpt":"On April 15, 2024, Dr. Simon Pimstone, chair of the board of directors (the “Board”) of Xenon Pharmaceuticals Inc. (the “Company”), and Dr. Mohammad Azab, a member of the Board, each informed the Company of their respective decisions not to stand for re-election to the Board at the Company’s 2024 annual meeting of shareholders (the “AGM”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017024046023/0000950170-24-046023-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"Chair of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}